Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-1990 | 06-1990 | 03-1990 | 12-1989 | 09-1989 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 307,900 | 399,100 | 388,900 | 825,400 | 568,600 |
Marketable Securities | 101,300 | 870,000 | 187,400 | 1,063,700 | 110,600 |
Receivables | 1,446,500 | 1,280,900 | 1,294,900 | 1,233,500 | 1,262,800 |
Inventories | 1,215,300 | 1,168,900 | 1,125,300 | 1,080,500 | 1,074,700 |
Other current assets | 813,400 | 243,900 | 1,049,600 | 301,700 | 779,400 |
TOTAL | $3,884,400 | $3,962,800 | $4,046,100 | $4,504,800 | $3,796,100 |
Non-Current Assets | |||||
PPE Net | 3,769,600 | 3,518,300 | 3,398,300 | 3,252,500 | 3,277,000 |
Investments And Advances | 0 | 0 | 0 | 1,103,300 | 0 |
Other Non-Current Assets | 2,530,600 | 2,188,500 | 2,045,400 | 932,600 | 2,193,500 |
TOTAL | $6,300,200 | $5,706,800 | $5,443,700 | $5,288,400 | $5,470,500 |
Total Assets | $8,530,200 | $8,100,400 | $7,954,700 | $8,324,800 | $7,726,300 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 0 | 0 | 0 | 0 | 4,900 |
Accounts payable and accrued liabilities | 418,000 | 379,000 | 370,900 | 401,400 | 354,200 |
Accrued Expenses | 230,100 | 245,500 | 229,500 | 236,500 | 216,300 |
Other current liabilities | 475,900 | 608,000 | 488,300 | 479,200 | 372,100 |
TOTAL | $2,675,300 | $2,578,300 | $2,351,800 | $2,911,600 | $2,318,300 |
Non-Current Liabilities | |||||
Long Term Debt | 189,900 | 181,800 | 189,600 | 190,600 | 207,400 |
Other Non-Current Liabilities | 158,000 | 148,000 | 139,200 | 136,100 | 114,500 |
TOTAL | $840,800 | $842,400 | $862,600 | $877,400 | $881,000 |
Total Liabilities | $3,486,800 | $3,394,000 | $3,188,800 | $3,789,000 | $3,175,500 |
Shareholders' Equity | |||||
Common Shares | 16,500 | 16,500 | 16,500 | 16,500 | 16,500 |
Retained earnings | 4,454,300 | 4,211,000 | 4,258,100 | 4,105,400 | 4,109,500 |
Other shareholders' equity | 228,700 | 105,800 | 112,900 | 47,400 | -6,500 |
TOTAL | $5,014,100 | $4,679,700 | $4,740,300 | $4,535,800 | $4,527,000 |
Total Liabilities And Equity | $8,500,900 | $8,073,700 | $7,929,100 | $8,324,800 | $7,702,500 |